3.00
-0.66%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Arterra Bioscience SpA
Its shares trade on Borsa Italiana under the ticker ARBS.MI. It has been listed since 28 October 2019. In the fiscal year to 31 December 2025, it reported revenue of €4.6m and net income of €2.0m. At that date it held total assets of €14.6m and shareholders' equity of €12.6m.
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli. The company went IPO on 2019-10-28. The company focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 28 Oct 2019
- Employees
- 30
- Website
- arterrabio.it ↗
Leadership
Pay as last reported
- Maria Gabriella ColucciChairman & Chief Executive Officer, since 2003
- Gualtiero IoimoChief Financial Officer, Director & Manager-IR, since 2019
- Fabio Apone, PhDDirector & Scientific Director, since 2003
- Maria Gabriella ColucciChairman & Chief Executive Officer, since 2003
- Gualtiero IoimoChief Financial Officer, Director & Manager-IR, since 2019
- Fabio Apone, PhDDirector & Scientific Director, since 2003
- Vittorio Turinetti di PrieroDirector, since 2019
- Luigi NicolaisIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Arterra Bioscience SpA employs 30 full-time employees focused on R&D in Naples, Italy.
- The company develops natural solutions using bacteria, yeasts, and plant cells for cosmetics and agriculture.
- Arterra collaborates with global universities and research institutes for innovative product development.
Weaknesses
- Arterra Bioscience SpA has a small workforce of 30 employees limiting scalability.
- The company's IPO on 28 October 2019 may indicate limited market traction.
- Arterra's focus on R&D without commercialized products could hinder revenue growth.
Opportunities
- Arterra can expand its natural solutions in the growing nutraceutics market.
- The company can leverage global collaborations to enter new industrial sectors.
- Arterra's technological platforms for active compound screening offer potential for partnerships.
Threats
- Arterra faces competition from established players in the cosmetics and agriculture sectors.
- The company's reliance on R&D without commercial products may lead to funding challenges.
- Regulatory changes in the nutraceutics industry could impact Arterra's product development.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.